Cargando…

Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease

This randomized clinical trial tested a new self-directed educational intervention to improve caregiver competence to create a safer home environment for persons with dementia living in the community. The sample included 108 patient/caregiver dyads: the intervention group (n = 60) received the Home...

Descripción completa

Detalles Bibliográficos
Autores principales: Horvath, Kathy J., Trudeau, Scott A., Rudolph, James L., Trudeau, Paulette A., Duffy, Mary E., Berlowitz, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804449/
https://www.ncbi.nlm.nih.gov/pubmed/24195007
http://dx.doi.org/10.1155/2013/913606
_version_ 1782288146284675072
author Horvath, Kathy J.
Trudeau, Scott A.
Rudolph, James L.
Trudeau, Paulette A.
Duffy, Mary E.
Berlowitz, Dan
author_facet Horvath, Kathy J.
Trudeau, Scott A.
Rudolph, James L.
Trudeau, Paulette A.
Duffy, Mary E.
Berlowitz, Dan
author_sort Horvath, Kathy J.
collection PubMed
description This randomized clinical trial tested a new self-directed educational intervention to improve caregiver competence to create a safer home environment for persons with dementia living in the community. The sample included 108 patient/caregiver dyads: the intervention group (n = 60) received the Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items to enhance self-efficacy to make home safety modifications. The control group (n = 48) received customary care. Participants completed measures at baseline and at twelve-week follow-up. Multivariate Analysis of Covariance (MANCOVA) was used to test for significant group differences. All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P ≤ 0.001, caregiver strain at P ≤ 0.001, and caregiver self-efficacy at P = 0.002. Similarly, the care receiver outcome of risky behaviors and accidents was lower in the intervention group (P ≤ 0.001). The self-directed use of this Home Safety Toolkit activated the primary family caregiver to make the home safer for the person with dementia of Alzheimer's type (DAT) or related disorder. Improving the competence of informal caregivers is especially important for patients with DAT in light of all stakeholders reliance on their unpaid care.
format Online
Article
Text
id pubmed-3804449
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38044492013-11-05 Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease Horvath, Kathy J. Trudeau, Scott A. Rudolph, James L. Trudeau, Paulette A. Duffy, Mary E. Berlowitz, Dan Int J Alzheimers Dis Clinical Study This randomized clinical trial tested a new self-directed educational intervention to improve caregiver competence to create a safer home environment for persons with dementia living in the community. The sample included 108 patient/caregiver dyads: the intervention group (n = 60) received the Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items to enhance self-efficacy to make home safety modifications. The control group (n = 48) received customary care. Participants completed measures at baseline and at twelve-week follow-up. Multivariate Analysis of Covariance (MANCOVA) was used to test for significant group differences. All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P ≤ 0.001, caregiver strain at P ≤ 0.001, and caregiver self-efficacy at P = 0.002. Similarly, the care receiver outcome of risky behaviors and accidents was lower in the intervention group (P ≤ 0.001). The self-directed use of this Home Safety Toolkit activated the primary family caregiver to make the home safer for the person with dementia of Alzheimer's type (DAT) or related disorder. Improving the competence of informal caregivers is especially important for patients with DAT in light of all stakeholders reliance on their unpaid care. Hindawi Publishing Corporation 2013 2013-09-29 /pmc/articles/PMC3804449/ /pubmed/24195007 http://dx.doi.org/10.1155/2013/913606 Text en Copyright © 2013 Kathy J. Horvath et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Horvath, Kathy J.
Trudeau, Scott A.
Rudolph, James L.
Trudeau, Paulette A.
Duffy, Mary E.
Berlowitz, Dan
Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title_full Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title_fullStr Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title_full_unstemmed Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title_short Clinical Trial of a Home Safety Toolkit for Alzheimer's Disease
title_sort clinical trial of a home safety toolkit for alzheimer's disease
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804449/
https://www.ncbi.nlm.nih.gov/pubmed/24195007
http://dx.doi.org/10.1155/2013/913606
work_keys_str_mv AT horvathkathyj clinicaltrialofahomesafetytoolkitforalzheimersdisease
AT trudeauscotta clinicaltrialofahomesafetytoolkitforalzheimersdisease
AT rudolphjamesl clinicaltrialofahomesafetytoolkitforalzheimersdisease
AT trudeaupaulettea clinicaltrialofahomesafetytoolkitforalzheimersdisease
AT duffymarye clinicaltrialofahomesafetytoolkitforalzheimersdisease
AT berlowitzdan clinicaltrialofahomesafetytoolkitforalzheimersdisease